Maccura Biotechnology Co.Ltd

SZSE:300463 Stock Report

Market Cap: CN¥7.0b

Maccura BiotechnologyLtd Future Growth

Future criteria checks 3/6

Maccura BiotechnologyLtd is forecast to grow earnings and revenue by 25.4% and 11.7% per annum respectively. EPS is expected to grow by 25.3% per annum. Return on equity is forecast to be 8.2% in 3 years.

Key information

25.4%

Earnings growth rate

25.3%

EPS growth rate

Life Sciences earnings growth27.9%
Revenue growth rate11.7%
Future return on equity8.2%
Analyst coverage

Low

Last updated12 Aug 2024

Recent future growth updates

Recent updates

Is Maccura BiotechnologyLtd (SZSE:300463) Using Too Much Debt?

Aug 01
Is Maccura BiotechnologyLtd (SZSE:300463) Using Too Much Debt?

Many Still Looking Away From Maccura Biotechnology Co.Ltd (SZSE:300463)

May 28
Many Still Looking Away From Maccura Biotechnology Co.Ltd (SZSE:300463)

Some Investors May Be Willing To Look Past Maccura BiotechnologyLtd's (SZSE:300463) Soft Earnings

May 01
Some Investors May Be Willing To Look Past Maccura BiotechnologyLtd's (SZSE:300463) Soft Earnings

Earnings and Revenue Growth Forecasts

SZSE:300463 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,7786646008613
12/31/20253,3775443487713
12/31/20243,0594341107193
6/30/20242,794340-292704N/A
3/31/20242,836316-255739N/A
12/31/20232,89631324902N/A
9/30/20233,005376-174856N/A
6/30/20233,207477-177831N/A
3/31/20233,360623-62890N/A
1/1/20233,608708-145843N/A
9/30/20223,6907616201,342N/A
6/30/20223,8028319121,590N/A
3/31/20223,8368451,0371,650N/A
1/1/20223,9819571,0151,617N/A
9/30/20214,1841,0248871,608N/A
6/30/20214,2121,0157141,379N/A
3/31/20214,2551,0325461,109N/A
12/31/20203,7047945931,094N/A
9/30/20203,405677388738N/A
6/30/20203,158565258589N/A
3/31/20203,019482128578N/A
12/31/20193,223525-45460N/A
9/30/20193,078504-245239N/A
6/30/20192,956483-247284N/A
3/31/20192,889463-281240N/A
12/31/20182,685445-336194N/A
9/30/20182,568431-392114N/A
6/30/20182,373413-45937N/A
3/31/20182,126394N/A15N/A
12/31/20171,970374N/A79N/A
9/30/20171,798365N/A86N/A
6/30/20171,663340N/A88N/A
3/31/20171,570324N/A95N/A
12/31/20161,489312N/A49N/A
9/30/20161,364303N/A6N/A
6/30/20161,220279N/A-10N/A
3/31/20161,139271N/A14N/A
12/31/20151,065251N/A33N/A
9/30/20151,024244N/A101N/A
6/30/2015997243N/A52N/A
3/31/2015959231N/A139N/A
12/31/2014935226N/A115N/A
12/31/2013779193N/A98N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300463's forecast earnings growth (25.4% per year) is above the savings rate (2.9%).

Earnings vs Market: 300463's earnings (25.4% per year) are forecast to grow faster than the CN market (21.8% per year).

High Growth Earnings: 300463's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300463's revenue (11.7% per year) is forecast to grow slower than the CN market (13.4% per year).

High Growth Revenue: 300463's revenue (11.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300463's Return on Equity is forecast to be low in 3 years time (8.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y